Pure Global
NCT06138652

Reducing Anxiety Levels Through the Dharma Life App-Based and Mentor-Based Program Targeting Personality Characteristics: A Randomized Control Trial

Dharma Life Sciences LLC·ClinicalTrials.gov·behavioralCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Anxiety
Drug/Device/Intervention
App
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Dharma Life Sciences LLC
Location
New York, United States of America
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2021
End date
Jan 31, 2022
Enrollment
73 participants
Primary outcome

Beck Anxiety Inventory,GAD-7

Summary

The purpose of this study was to examine whether an app- and mentor-based program reduced
 anxiety among individuals reporting difficulties with anxiety.
 
 For the intervention group, this study involved completing an 8-week program focused on
 helping participants reach their personality goals. The program involved app-based games,
 journaling, and completing behavioral challenges. Participants engaged with the study app for
 approximately 15 minutes per day and spoke with a study mentor weekly for 1 hour.
 Participants were asked to complete surveys prior to and after the program. The pre-program
 survey lasted approximately 1 hour, and the post-program survey lasted approximately 30
 minutes.
 
 For the control group, this study involved completing surveys. Participants were asked to
 complete surveys 8 weeks apart. The first batch of surveys lasted approximately 1 hour, and
 the follow-up surveys lasted approximately 30 minutes.

ICD-10 classifications
Anxiety disorder, unspecifiedOther anxiety disordersPhobic anxiety disordersPhobic anxiety disorder, unspecifiedGeneralized anxiety disorder
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06138652
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06138652 through Pure Global AI's free database. This phase not specified trial is sponsored by Dharma Life Sciences LLC and is currently Completed. The study focuses on Anxiety. Target enrollment is 73 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.